{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:56:39Z","timestamp":1790268999074,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbr.2025.115785","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T14:59:34Z","timestamp":1755961174000},"page":"115785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Therapeutic implications of allopregnanolone in Alzheimer\u2019s related depression"],"prefix":"10.1016","volume":"495","author":[{"given":"Balaji","family":"Tidke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Itekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Khobragade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura","family":"Vinchurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2025.115785_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-180802","article-title":"Understanding the amyloid hypothesis in Alzheimer\u2019s disease","volume":"68","author":"Paroni","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"55","key":"10.1016\/j.bbr.2025.115785_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1134\/S002689332104004X","article-title":"Beta amyloid, tau protein, and neuroinflammation: an attempt to integrate different hypotheses of Alzheimer\u2019s disease pathogenesis","volume":"5","author":"Garbuz","year":"2021","journal-title":"Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib3","unstructured":"A.Faraz Khan, Integrating neurotransmitter receptor architecture in whole-brain computational models of neurodegenerative disease progression, (2024)."},{"key":"10.1016\/j.bbr.2025.115785_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1161850","article-title":"Revisiting the neuroinflammation hypothesis in Alzheimer\u2019s disease: a focus on the druggability of current targets","volume":"14","author":"Wong-Guerra","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.bbr.2025.115785_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2105607","article-title":"Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view","volume":"2019","author":"Cenini","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bbr.2025.115785_bib6","article-title":"Steroid hormone sensitivity in reproductive mood disorders: on the role of the GABAA receptor complex and stress during hormonal transitions","volume":"7","author":"Schweizer-Schubert","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.bbr.2025.115785_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2025.115785_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1201\/9781846198465-44","article-title":"Mental disorders due to physical illness at the interface: practical considerations","author":"Katz-Bearnot","year":"2022","journal-title":"Companion Prim. Care Ment. Health"},{"key":"10.1016\/j.bbr.2025.115785_bib9","first-page":"899","article-title":"Disease, undefined 2018, behavioral and neuropsychiatric disorders in Alzheimer\u2019s disease","volume":"63","author":"Cort\u00e9s","year":"2018","journal-title":"J. Sagepub. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1092537","article-title":"Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders","volume":"17","author":"Kip","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2025.115785_bib11","article-title":"Undefined 2021, ACNP 60th annual meeting: panels, mini-panels and study groups","author":"Neuropsychopharmacology","year":"2011","journal-title":"Nat. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib12","unstructured":"L.A.-W.J.P.P. Sci, undefined 2021, A comprehensive review on Alzheimer\u2019s disease, Academia.Edu (n.d.). \u3008https:\/\/www.academia.edu\/download\/74422488\/A_COMPREHENSIVE_REVIEW_ON_ALZHEIMER_S_DISEASE.pdf\u3009 (accessed February 13, 2025)."},{"key":"10.1016\/j.bbr.2025.115785_bib13","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2020","journal-title":"Springer"},{"key":"10.1016\/j.bbr.2025.115785_bib14","unstructured":"M. Johansson, Neuropsychiatric symptoms in early stages of Alzheimer\u2019s disease: associations with neuropathological changes and cognitive deficits, (2022). \u3008https:\/\/portal.research.lu.se\/files\/116710578\/Thesis_summary_Maurits_Johansson_without_articles_and_appendix.pdf\u3009 (accessed February 13, 2025)."},{"key":"10.1016\/j.bbr.2025.115785_bib15","first-page":"879","article-title":"Depressive and biopsychosocial frailty phenotypes: impact on late-life cognitive disorders","volume":"94","author":"Panza","year":"2023","journal-title":"Content Iospress. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib16","article-title":"Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges","volume":"11","author":"Safiri","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.bbr.2025.115785_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104961","article-title":"Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and impediments","volume":"144","author":"Rehman","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2025.115785_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102086","article-title":"Impose of KNDy\/GnRH neural circuit in PCOS, ageing, cancer and Alzheimer\u2019s disease: StAR actions in prevention of neuroendocrine dysfunction","volume":"92","author":"Panda","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbr.2025.115785_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2174\/1570159X21666230428091433","article-title":"Treatment of posttraumatic stress disorder: a state-of-the-art review","volume":"22","author":"Burback","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbr.2025.115785_bib20","series-title":"Allopregnanolone: regenerative therapeutic to restore neurological health","author":"Hernandez","year":"2022"},{"key":"10.1016\/j.bbr.2025.115785_bib21","first-page":"649","article-title":"The GABAergic system as a therapeutic target for Alzheimer\u2019s disease","volume":"146","author":"Guzm\u00e1n","year":"2018","journal-title":"Wiley Online Libr."},{"issue":"5","key":"10.1016\/j.bbr.2025.115785_bib22","first-page":"582","article-title":"Neuroactive steroids, toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders","volume":"14","author":"Balan","year":"2024","journal-title":"Life (Basel)"},{"issue":"9","key":"10.1016\/j.bbr.2025.115785_bib23","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/acer.15404","article-title":"Neurosteroid [3\u03b1,5\u03b1]3-hydroxypregnan-20-one inhibition of chemokine monocyte chemoattractant protein-1 in alcohol-preferring rat brain neurons, microglia, and astroglia","volume":"48","author":"Chery","year":"2024","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.bbr.2025.115785_bib24","first-page":"860","article-title":"Neurosteroid [3\u03b1,5\u03b1]-3-hydroxy-pregnan-20-one enhances the CX3CL1-CX3CR1 pathway in the brain of alcohol-preferring rats with sex-specificity","volume":"14","author":"Balan","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.bbr.2025.115785_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1567205020666230811092956","article-title":"Early chronic stress induced changes within the locus coeruleus in sporadic Alzheimer\u2019s disease","volume":"20","author":"Minne","year":"2023","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2025.115785_bib26","article-title":"Royal jelly as an intelligent anti-aging agent\u2014A focus on cognitive aging and Alzheimer\u2019s disease: a review","volume":"10","author":"Kumar Jha","year":"2020","journal-title":"Mdpi. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570159X20666220411083922","article-title":"Strategies for treatment of disease-associated dementia beyond Alzheimer\u2019s disease: an update","volume":"21","author":"Khan","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbr.2025.115785_bib28","first-page":"309","article-title":"Strategies for treatment of disease-associated dementia beyond Alzheimer\u2019s disease: an update","volume":"21","author":"Khan","year":"2023","journal-title":"Benthamdirect. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.wneu.2024.05.104","article-title":"Bridging minds and machines: the recent advances of brain-computer interfaces in neurological and neurosurgical applications","volume":"189","author":"Awuah","year":"2024","journal-title":"World Neurosurg."},{"key":"10.1016\/j.bbr.2025.115785_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01523","article-title":"Zolpidem activation of alpha 1-containing GABAA receptors selectively inhibits high frequency action potential firing of cortical neurons","volume":"9","author":"Neumann","year":"2019","journal-title":"Front. Pharm."},{"key":"10.1016\/j.bbr.2025.115785_bib31","doi-asserted-by":"crossref","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative toxicogenomics database (CTD): update 2023","volume":"51","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbr.2025.115785_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.chest.2024.09.019","article-title":"Impact of cystic fibrosis transmembrane conductance regulator modulators on maternal outcomes during and after pregnancy","volume":"167","author":"Jain","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.bbr.2025.115785_bib33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Promoting positive cognitive and intellectual maintenance across the lifespan","volume":"36","author":"Camandola","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.bbr.2025.115785_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105668","article-title":"Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment","volume":"161","author":"B\u00e4ckstr\u00f6m","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2025.115785_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115785_bib36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/NDT.S199746","article-title":"Cognitive impairment in depression: recent advances and novel treatments","volume":"15","author":"Perini","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2025.115785_bib37","article-title":"Neurosteroids and early-life programming: an updated perspective","volume":"25","author":"Sze","year":"2022","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.bbr.2025.115785_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105682","article-title":"Allopregnanolone in mood disorders: mechanism and therapeutic development","volume":"169","author":"Chen","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbr.2025.115785_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00161","article-title":"General adaptation in critical illness: glucocorticoid Receptor-alpha master regulator of homeostatic corrections","volume":"11","author":"Meduri","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbr.2025.115785_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101208","article-title":"Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria","volume":"65","author":"John","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbr.2025.115785_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100213","article-title":"Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle","volume":"12","author":"Hantsoo","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.bbr.2025.115785_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105558","article-title":"Emerging evidence for endogenous neurosteroid modulation of pro-inflammatory and anti-inflammatory pathways that impact neuropsychiatric disease","volume":"158","author":"Morrow","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2025.115785_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/2470547018818555","article-title":"Overview of the molecular steps in steroidogenesis of the GABAergic neurosteroids allopregnanolone and pregnanolone","volume":"2","author":"Liang","year":"2018","journal-title":"Chronic Stress"},{"key":"10.1016\/j.bbr.2025.115785_bib45","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.65866","article-title":"The emerging role of neurosteroids: novel drugs brexanalone, sepranolone, zuranolone, and ganaxolone in mood and neurological disorders","author":"Singhal","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bbr.2025.115785_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.04.008","article-title":"The role of vitamin d in the endocrinology controlling calcium homeostasis","volume":"453","author":"Fleet","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbr.2025.115785_bib47","unstructured":"L.V.-J. of P. Investigation, undefined 2020, Physiological and pathological functions of beta-amyloid in the brain and Alzheimer\u2019s disease: a review, Journals.Lww.Com (n.d.). \u3008https:\/\/journals.lww.com\/cjop\/_layouts\/15\/oaks.journals\/downloadpdf.aspx?an=00002964-202063030-00001\u3009 (accessed February 13, 2025)."},{"key":"10.1016\/j.bbr.2025.115785_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-024-01359-x","article-title":"Monoamine alterations in Alzheimer\u2019s disease and their implications in comorbid neuropsychiatric symptoms","author":"Saggu","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.bbr.2025.115785_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-021-02449-2","article-title":"Recent update on the heterogeneity of the Alzheimer\u2019s disease spectrum","volume":"129","author":"Jellinger","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2025.115785_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1567205020666230811092956","article-title":"Early chronic stress induced changes within the locus coeruleus in sporadic Alzheimer\u2019s disease","volume":"20","author":"Minn\u00e9","year":"2023","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2025.115785_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-023-09170-1","article-title":"Converged avenues: depression and Alzheimer\u2019s disease\u2013 shared pathophysiology and novel therapeutics","volume":"51","author":"Bajaj","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbr.2025.115785_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-024-02790-2","article-title":"Inflammatory aspects of Alzheimer\u2019s disease","volume":"148","author":"Botella Lucena","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2025.115785_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","article-title":"Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review","volume":"37","author":"Rekatsina","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bbr.2025.115785_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00386","article-title":"Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression","volume":"12","author":"Allen","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2025.115785_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1039725","article-title":"The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer\u2019s disease","volume":"13","author":"Krashia","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115785_bib56","article-title":"Insight into the functional dynamics and challenges of exosomes in pharmaceutical innovation and precision medicine","author":"Sharma","year":"2024","journal-title":"Mdpi. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib57","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2025.115785_bib58","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s12035-022-02725-6","article-title":"Neuroinflammation and proinflammatory cytokines in epileptogenesis","volume":"59","author":"Soltani Khaboushan","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115785_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.bbr.2025.115785_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","article-title":"Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s disease","volume":"82","author":"Ekundayo","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbr.2025.115785_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.620371","article-title":"Postpartum depression: current status and possible identification using biomarkers","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115785_bib62","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1212\/WNL.0000000000009781","article-title":"Sex-driven modifiers of alzheimer risk: a multimodality brain imaging study","volume":"95","author":"Rahman","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115785_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2021.06.037","article-title":"The role of the GABAergic system in diseases of the central nervous system","volume":"470","author":"Zhang","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2025.115785_bib65","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3390\/nu16203459","article-title":"In vitro mechanistic studies of a standardized sustainable grape seed extract for potential application as a mood-modulating and cognition-enhancing supplement","volume":"16","author":"Hasbal-Celikok","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bbr.2025.115785_bib66","series-title":"Cognitive Informatics, Computer Modelling, and Cognitive Science","first-page":"21","article-title":"Functional neuroanatomy and disorders of cognition","author":"Nakhate","year":"2020"},{"key":"10.1016\/j.bbr.2025.115785_bib67","doi-asserted-by":"crossref","first-page":"442","DOI":"10.37349\/ent.2024.00093","article-title":"Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review","author":"Herrera","year":"2024","journal-title":"Explor. Neuroprotective Ther."},{"key":"10.1016\/j.bbr.2025.115785_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150218","article-title":"GABAergic implications in anxiety and related disorders","volume":"724","author":"Arora","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbr.2025.115785_bib69","article-title":"Brain intracrinology of allopregnanolone during pregnancy and hormonal contraception","volume":"37","author":"Pluchino","year":"2019","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.bbr.2025.115785_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7743705","article-title":"Perspectives on the molecular mediators of oxidative stress and antioxidant strategies in the context of neuroprotection and neurolongevity: an extensive review","volume":"2022","author":"Shohag","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bbr.2025.115785_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsbmb.2015.02.008","article-title":"Learning and memory: steroids and epigenetics","volume":"150","author":"Colciago","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2022.102229","article-title":"The effects of neurosteroid allopregnanolone on synaptic dysfunction in the hippocampus in experimental parkinsonism rats: an electrophysiological and molecular study","volume":"92","author":"Sheibani","year":"2022","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2025.115785_bib73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00042.2023","article-title":"Neurobiology and systems biology of stress resilience","volume":"104","author":"Kalisch","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbr.2025.115785_bib74","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.3390\/ijms231911076","article-title":"New insights into the pivotal role of the amygdala in Inflammation-Related depression and anxiety disorder","volume":"23","author":"Hu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115785_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2022.111686","article-title":"Redox modulation of stress resilience by crocus sativus L. For potential neuroprotective and anti-neuroinflammatory applications in brain disorders: from molecular basis to therapy","volume":"205","author":"Scuto","year":"2022","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbr.2025.115785_bib76","article-title":"Exploratory imaging outcomes of a phase 1b\/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: structural effects and functional connectivity outcomes","volume":"8","author":"Raikes","year":"2022","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.bbr.2025.115785_bib77","doi-asserted-by":"crossref","unstructured":"A.V. Skalny, M. Aschner, Y. Jiang, Y.G. Gluhcheva, Y. Tizabi, R. Lobinski, A.A. Tinkov, Molecular mechanisms of aluminum neurotoxicity: Update on adverse effects and therapeutic strategies, in: 2021: pp. 1\u201334. https:\/\/doi.org\/10.1016\/bs.ant.2020.12.001.","DOI":"10.1016\/bs.ant.2020.12.001"},{"key":"10.1016\/j.bbr.2025.115785_bib78","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.3390\/ijms19113650","article-title":"Actions of Brain-Derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases","volume":"19","author":"Numakawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115785_bib79","series-title":"Steroids, neuroactive steroids and neurosteroids in psychopathology","author":"in N.-P","year":"2005"},{"key":"10.1016\/j.bbr.2025.115785_bib80","article-title":"Neurosteroids: mechanistic considerations and clinical prospects","author":"Maguire","year":"2024","journal-title":"Nat. Com."},{"key":"10.1016\/j.bbr.2025.115785_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib82","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/life14050582","article-title":"Neuroactive steroids, Toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders","volume":"14","author":"Balan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.bbr.2025.115785_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108609","article-title":"Mechanistic and therapeutic relationships of traumatic brain injury and \u03b3-amino-butyric acid (GABA)","volume":"256","author":"Witkin","year":"2024","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.bbr.2025.115785_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2013.08.004","article-title":"Allopregnanolone as regenerative therapeutic for Alzheimer\u2019s disease: translational development and clinical promise","volume":"113","author":"Irwin","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115785_bib85","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3390\/nu12102977","article-title":"Metabolic defects caused by High-Fat diet modify disease risk through inflammatory and amyloidogenic pathways in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Reilly","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbr.2025.115785_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100213","article-title":"Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle","volume":"12","author":"Hantsoo","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.bbr.2025.115785_bib88","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/1567205013666160502123607","article-title":"Neuropsychiatric disturbances in Alzheimer\u2019s disease: what have we learned from neuropathological studies?","volume":"13","author":"Van Dam","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2025.115785_bib89","series-title":"The Science of Health Disparities Research","first-page":"13","article-title":"Getting under the skin","author":"Jackson","year":"2021"},{"key":"10.1016\/j.bbr.2025.115785_bib90","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12035-023-03574-7","article-title":"The role of extrasynaptic GABA receptors in postpartum depression","volume":"61","author":"Feng","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115785_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.972158","article-title":"Molecular actions of sex hormones in the brain and their potential treatment use in anxiety disorders","volume":"13","author":"Pillerov\u00e1","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115785_bib92","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbi.2017.10.025","article-title":"Depression and sterile inflammation: essential role of danger associated molecular patterns","volume":"72","author":"Franklin","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2025.115785_bib93","article-title":"Characterization of brain abnormalities in lactational neurodevelopmental poly I:C rat model of schizophrenia and depression using Machine-Learning and quantitative MRI","author":"Haker","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.bbr.2025.115785_bib94","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/life14050582","article-title":"Neuroactive steroids, Toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders","volume":"14","author":"Balan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.bbr.2025.115785_bib95","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/ph16040520","article-title":"Progesterone and its metabolites play a beneficial role in affect regulation in the female brain","volume":"16","author":"Stefaniak","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbr.2025.115785_bib96","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1212\/WNL.0000000000004425","article-title":"Sex differences in Alzheimer risk","volume":"89","author":"Mosconi","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115785_bib97","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.psyneuen.2016.05.010","article-title":"Peripartum neuroactive steroid and \u03b3-aminobutyric acid profiles in women at-risk for postpartum depression","volume":"70","author":"Deligiannidis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2025.115785_bib98","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41431-021-00859-0","article-title":"Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases","volume":"29","author":"Zurek","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbr.2025.115785_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00256","article-title":"Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder","volume":"8","author":"Pinna","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.bbr.2025.115785_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106169","article-title":"Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson\u2019s disease","volume":"183","author":"Luchetti","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2025.115785_bib101","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"<scp>APP<\/scp> mouse models for Alzheimer\u2019s disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.bbr.2025.115785_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12996","article-title":"Allopregnanolone: an overview on its synthesis and effects","volume":"34","author":"Diviccaro","year":"2022","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.bbr.2025.115785_bib103","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/156720501304160314162812","article-title":"Neurorestorative role of stem cells in Alzheimer\u2019s disease: astrocyte involvement","volume":"13","author":"S. Choi","year":"2016","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.bbr.2025.115785_bib104","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2011.06.008","article-title":"Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nontg mice","volume":"33","author":"Singh","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2025.115785_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbr.2025.115785_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105682","article-title":"Allopregnanolone in mood disorders: mechanism and therapeutic development","volume":"169","author":"Chen","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbr.2025.115785_bib107","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/1028415X.2020.1751508","article-title":"Anhedonia induced by high-fat diet in mice depends on gut microbiota and leptin","volume":"25","author":"Hassan","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbr.2025.115785_bib108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543784.12.1.65","article-title":"Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future","volume":"12","author":"Farvolden","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bbr.2025.115785_bib109","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-170239","article-title":"Impact of neuroinflammation on hippocampal neurogenesis: relevance to aging and Alzheimer\u2019s disease","volume":"60","author":"Valero","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbr.2025.115785_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2024.1380002","article-title":"Contributions of loneliness to cognitive impairment and dementia in older adults are independent of other risk factors and Alzheimer\u2019s pathology: a narrative review","volume":"18","author":"Oken","year":"2024","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.bbr.2025.115785_bib111","article-title":"Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: a single and multiple ascending dose phase 1b\/2a clinical trial","volume":"6","author":"Hernandez","year":"2020","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.bbr.2025.115785_bib112","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14737175.2021.1956904","article-title":"The APOE \u03b54 variant and hippocampal atrophy in Alzheimer\u2019s disease and lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance","volume":"21","author":"Saeed","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbr.2025.115785_bib113","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/ph16111572","article-title":"Pharmacotherapies targeting GABA-Glutamate neurotransmission for Treatment-Resistant depression","volume":"16","author":"Vecera","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbr.2025.115785_bib114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13651501.2016.1254802","article-title":"Administration of ketamine for unipolar and bipolar depression","volume":"21","author":"Kraus","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.bbr.2025.115785_bib115","series-title":"Nanotechnology in Functional Foods","first-page":"161","article-title":"Lipid nanoformulation of nutraceuticals as neurotherapeuticals in neurological disorders","author":"Taleuzzaman","year":"2022"},{"key":"10.1016\/j.bbr.2025.115785_bib116","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14737159.2024.2399152","article-title":"How can we improve the successful identification of patients suitable for CAR-T cell therapy?","volume":"24","author":"Feng","year":"2024","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.bbr.2025.115785_bib117","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/life14050582","article-title":"Neuroactive steroids, Toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders","volume":"14","author":"Balan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.bbr.2025.115785_bib118","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.2174\/1381612828666220411104128","article-title":"Phytochemical compounds loaded to nanocarriers as potential therapeutic substances for Alzheimer\u2019s Disease-could they be effective?","volume":"28","author":"Polat","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2025.115785_bib119","first-page":"11","article-title":"Recent progress in the oral delivery of therapeutic peptides and proteins: overview of pharmaceutical strategies to overcome absorption hurdles","volume":"14","author":"Mehrotra","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.bbr.2025.115785_bib120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2013.08.004","article-title":"Allopregnanolone as regenerative therapeutic for Alzheimer\u2019s disease: translational development and clinical promise","volume":"113","author":"Irwin","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115785_bib121","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.3390\/ijms251910834","article-title":"Cyclodextrin-Containing drug delivery systems and their applications in neurodegenerative disorders","volume":"25","author":"Xing","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115785_bib122","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/pharmaceutics13101570","article-title":"Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases","volume":"13","author":"Lim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbr.2025.115785_bib123","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543784.12.1.65","article-title":"Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future","volume":"12","author":"Farvolden","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bbr.2025.115785_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00203","article-title":"Frontiers in therapeutic development of allopregnanolone for Alzheimer\u2019s disease and other neurological disorders","volume":"8","author":"Irwin","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.bbr.2025.115785_bib125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tips.2004.12.010","article-title":"A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer\u2019s disease?","volume":"26","author":"Francis","year":"2005","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.bbr.2025.115785_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.860882","article-title":"The mechanisms behind rapid antidepressant effects of ketamine: a systematic review with a focus on molecular neuroplasticity","volume":"13","author":"Kang","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bbr.2025.115785_bib127","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/ph13100309","article-title":"Pharmacology of herbal sexual enhancers: a review of psychiatric and neurological adverse effects","volume":"13","author":"Brunetti","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbr.2025.115785_bib128","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2013.08.004","article-title":"Allopregnanolone as regenerative therapeutic for Alzheimer\u2019s disease: translational development and clinical promise","volume":"113","author":"Irwin","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115785_bib129","article-title":"Benefits of remimazolam as an anesthetic sedative for older patients: a review","volume":"10","author":"Jin","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbr.2025.115785_bib130","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bbr.2025.115785_bib131","article-title":"Exploratory imaging outcomes of a phase 1b\/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: structural effects and functional connectivity outcomes","volume":"8","author":"Raikes","year":"2022","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.bbr.2025.115785_bib132","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JAD-179901","article-title":"Clinical trials for Disease-Modifying therapies in Alzheimer\u2019s disease: a primer, lessons learned, and a blueprint for the future","volume":"64","author":"Cummings","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbr.2025.115785_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2025.100187","article-title":"Exploring the role of neuromodulation in neurodegenerative disorders: insights from Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"17","author":"Oyovwi","year":"2025","journal-title":"Brain Disord."},{"key":"10.1016\/j.bbr.2025.115785_bib134","doi-asserted-by":"crossref","unstructured":"R.M. Bonelli, M.F. Beal, Huntington\u2019s disease, in: 2012: pp. 507\u2013526. https:\/\/doi.org\/10.1016\/B978-0-444-52002-9.00030-9.","DOI":"10.1016\/B978-0-444-52002-9.00030-9"},{"key":"10.1016\/j.bbr.2025.115785_bib135","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14737175.2024.2355259","article-title":"An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men","volume":"24","author":"Marazziti","year":"2024","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbr.2025.115785_bib136","series-title":"Molecularly Imprinted Polymer Composites","first-page":"173","article-title":"Molecularly imprinted polymer composites in drug delivery","author":"Mazuryk","year":"2021"},{"key":"10.1016\/j.bbr.2025.115785_bib137","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/14789450.2018.1544894","article-title":"Could a blood test for PTSD and depression be on the horizon?","volume":"15","author":"Aspesi","year":"2018","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.bbr.2025.115785_bib138","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/jcm10081555","article-title":"Neuropathology of the brainstem to mechanistically understand and to treat Alzheimer\u2019s disease","volume":"10","author":"Patthy","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbr.2025.115785_bib139","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-019-00731-6","article-title":"Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases","volume":"16","author":"Petrov","year":"2019","journal-title":"Neurotherapeutics"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825003729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825003729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:05:40Z","timestamp":1758575140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432825003729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":139,"alternative-id":["S0166432825003729"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115785","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic implications of allopregnanolone in Alzheimer\u2019s related depression","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115785"}}